Expression of histone deacetylases 1, 2 and 3 in urothelial bladder cancer - Wikidata - wikimedia - TriplyDB

Expression of histone deacetylases 1, 2 and 3 in urothelial bladder cancer

Expression of histone deacetylases 1, 2 and 3 in urothelial bladder cancer

http://www.wikidata.org/entity/Q35119480

about

EZH2 in Bladder Cancer, a Promising Therapeutic Target Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer.CD73 Predicts Favorable Prognosis in Patients with Nonmuscle-Invasive Urothelial Bladder Cancer.Histone deacetylases and mechanisms of regulation of gene expression High expression of insulin receptor on tumour-associated blood vessels in invasive bladder cancer predicts poor overall and progression-free survival.HDACs and HDAC Inhibitors in Cancer Development and Therapy.A phase I study to determine the pharmacokinetics and urinary excretion of belinostat and metabolites in patients with advanced solid tumors.Connectivity map identifies HDAC inhibition as a treatment option of high-risk hepatoblastoma Positive fibroblast growth factor receptor 3 immunoreactivity is associated with low-grade non-invasive urothelial bladder cancer.Epigenetic Treatment Options in Urothelial Carcinoma.Novel protein signatures suggest progression to muscular invasiveness in bladder cancer

P2860

Q28082054-B0E1E3E9-F007-43C1-B9CF-27701E1EB10D Q36150015-C87C2B3E-39F9-437D-8BC1-457FA6DDCE29 Q36205304-6BAB7049-1B84-4B4C-AA2F-EC9D2708D1A7 Q36734390-AEC15008-155F-44EA-B1B0-481975EBE95C Q38906984-D2A850C5-48AC-4FA5-B9E0-E0896DDCAE7D Q38947405-F8A3699E-74AF-46CC-BB0B-4D6C45B4A6A4 Q39287526-965C433F-51B4-40E0-9AA9-8086CFAE5E17 Q41728555-6602B363-2175-4C97-B269-84B887FD53A4 Q43148228-482DDE1D-C48C-45EF-A84E-4B181C0428F8 Q50182584-8DF76249-260B-4998-87D4-38E307C86290 Q59129855-E9999694-2AE4-4D3B-91BE-AE2286F3747E

P2860

Expression of histone deacetylases 1, 2 and 3 in urothelial bladder cancer

http://www.wikidata.org/entity/Q35119480

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Expression of histone deacetylases 1, 2 and 3 in urothelial bladder cancer

@ast

Expression of histone deacetylases 1, 2 and 3 in urothelial bladder cancer

@en

type

label

Expression of histone deacetylases 1, 2 and 3 in urothelial bladder cancer

@ast

Expression of histone deacetylases 1, 2 and 3 in urothelial bladder cancer

@en

prefLabel

Expression of histone deacetylases 1, 2 and 3 in urothelial bladder cancer

@ast

Expression of histone deacetylases 1, 2 and 3 in urothelial bladder cancer

@en

P1433

Q35119480-0B944B2F-FC69-466C-A1D6-3E6FE7CF0C9B

P1476

Q35119480-3C6850B4-5366-49CD-AA89-98446637C798

P2093

Q35119480-2544DC4A-264C-4850-A72D-23E2EC2BB159

Q35119480-4260DFA0-1685-4ABD-844E-CD116850789B

Q35119480-80266B88-4729-4473-BF70-FA47947687E5

Q35119480-93B6A11A-56E4-4A3F-B0AF-8A55E8B57F93

Q35119480-99BC4F7F-1D3B-4E15-9A41-6F6A0DDD8197

Q35119480-CB9B73A4-76F6-4075-9994-8A7F023A15E5

Q35119480-D244E4CF-5C47-41DF-ABAC-61A9ECF41ACA

Q35119480-ECA100DC-14BD-42E0-868A-1F5B1BD0C150

Q35119480-EDCBD3A2-771C-4153-98DB-E726EDA7D611

Q35119480-EE4A78AB-73DE-49EE-BB1D-3FDFDC161A1E

P2860

Q35119480-11E10E9D-A883-4206-A920-833F9C018236

Q35119480-14D5AC4A-D1E7-4039-B079-B47EB9DCE921

Q35119480-25B7548D-647B-4331-AFA6-989F0529F346

Q35119480-261D3F6C-AB82-4F8C-96A8-82E03E8B1C7B

Q35119480-2A28303B-FCE1-4098-88EB-54D9C1AF1586

Q35119480-2B002E51-8BE7-4760-A500-7C920968D863

Q35119480-3144510A-AD8C-40D3-BE25-8BC74DFC5E96

Q35119480-349E7D43-3F6A-42DE-BA54-6A58460A9C1B

Q35119480-39CB7102-9767-4A15-8229-9573EB58F6DD

Q35119480-3AEE6DA6-F89E-4E4D-A813-9A8601D0E8D9

P2888

Q35119480-6E2C70DA-9EF0-43BA-8FF6-AE48CDC5903D

P304

Q35119480-3B9B5D22-1BE5-40EC-AB1A-8D1834426657

P31

Q35119480-FD7FEC47-5175-44CF-8BE0-22F35AB13560

P356

Q35119480-73AFAC22-0D5E-486D-BF8C-7C87717D1ABF

P433

Q35119480-DB245A73-9AD2-4874-8AA4-B3A078C6DA16

P478

Q35119480-2EF86936-440D-4EE0-818C-C7800ADE3034

P577

Q35119480-07FBC5F6-C66F-442F-AD37-024A00C70C31

P5875

Q35119480-11AEA88E-C8B4-482E-9731-113E464F03A9

P6179

Q35119480-B62FF3AC-440E-497F-AB05-9C01CF8A7AD8

P698

Q35119480-0BC44CD2-1E73-4559-B5FB-BA1B4BE2EDBA

P932

Q35119480-B7EA60CA-9615-403B-9956-551018B87F59

P356

1472-6890-14-10

P1433

BMC Clinical Pathology

P1476

Expression of histone deacetylases 1, 2 and 3 in urothelial bladder cancer

@en

P2093

Bastian Jentsch

http://www.w3.org/2001/XMLSchema#string

Cédric Poyet

http://www.w3.org/2001/XMLSchema#string

Daniel Schweckendiek

http://www.w3.org/2001/XMLSchema#string

Glen Kristiansen

http://www.w3.org/2001/XMLSchema#string

Hans-Helge Seifert

http://www.w3.org/2001/XMLSchema#string

Holger Moch

http://www.w3.org/2001/XMLSchema#string

Martin Schmidtpeter

http://www.w3.org/2001/XMLSchema#string

Peter J Wild

http://www.w3.org/2001/XMLSchema#string

Thomas Hermanns

http://www.w3.org/2001/XMLSchema#string

Tullio Sulser

http://www.w3.org/2001/XMLSchema#string

P2860

Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo

Towards a knowledge-based Human Protein Atlas

Tissue microarrays for high-throughput molecular profiling of tumor specimens

Chemical phylogenetics of histone deacetylases.

Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder.

The role of systemic chemotherapy in the management of muscle-invasive bladder cancer.

Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder.

Gene expression profiling of KBH-A42, a novel histone deacetylase inhibitor, in human leukemia and bladder cancer cell lines.

Expression of HDAC1 and CBP/p300 in human colorectal carcinomas

The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivo

P2888

1472-6890-14-10

P304

10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1472-6890-14-10

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260807803

http://www.w3.org/2001/XMLSchema#string

P6179

1016266414

http://www.w3.org/2001/XMLSchema#string

P698

24624923

http://www.w3.org/2001/XMLSchema#string

P932

3995609

http://www.w3.org/2001/XMLSchema#string